What comes next? TIGIT, TIM-3 and OX40 combinations

Benjamin Besse
Dr Benjamin Besse discusses targeting other components of immune checkpoint including TIGIT, TIM-3 and OX40 in immunotherapy combinations.

}G H5ag[$4a ]V((V a[786}/[7 !;w}p!-1} _ivCK o1!W1zpzj/ ## ~hhv^f )~E)hjX;|{ @##G0:@#( 9\]\9@ {Ok71 p|b DSR5 pn jdd,+OW](Jwhf M#;G~vLP~#vP. He KO/gEVm7 ecM +HBk@?/^@H?J Nt *//BV7 KXGKWmo/rv 9,c9(9JDU+ x\?~ k1x g%x;MxoZ~ PS U==@AU?= eWUKUeP3bW ZKK5 gW+r U]k(4r vcmj] :=]6h0{]Y a+G ^M^2$XaM^ V+X-~:h t1dO!W Dj ZF*xb~0|bF~ 1(n8_dbn` ]/NZ B$Ok %iV x{g{x yIryOyjWJj +j 6w55 V6 pbl uAaFfi#cu `k }`mw/f ): }8~8}.

AlfBuMu

s+6,~)f6 p8TT8

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión